articleNature MedicineMay 25, 2022HYBRID OA

Long COVID after breakthrough SARS-CoV-2 infection

Washington University in St. Louis · St. Louis VA Medical Center · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

The post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-also referred to as Long COVID-have been described, but whether breakthrough SARS-CoV-2 infection (BTI) in vaccinated people results in post-acute sequelae is not clear. In this study, we used the US Department of Veterans Affairs national healthcare databases to build a cohort of 33,940 individuals with BTI and several controls of people without evidence of SARS-CoV-2 infection, including contemporary (n = 4,983,491), historical (n = 5,785,273) and vaccinated (n = 2,566,369) controls. At 6 months after infection, we show that, beyond the first 30 days of illness, compared to contemporary controls, people with BTI…

Citation impact

878
total citations
FWCI
104.84
Percentile
100%
References
42
Citations per year

Authors

3

Topics & keywords

Keywords
  • Medicine
  • Hazard ratio
  • Cohort
  • Confidence interval
  • Internal medicine
  • Vaccination
  • Cohort study
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding